Yüklüyor......

Switching the Inhibitor‐Enzyme Recognition Profile via Chimeric Carbonic Anhydrase XII

A key part of the optimization of small molecules in pharmaceutical inhibitor development is to vary the molecular design to enhance complementarity of chemical features of the compound with the positioning of amino acids in the active site of a target enzyme. Typically this involves iterations of s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:ChemistryOpen
Asıl Yazarlar: Smirnovienė, Joana, Smirnov, Alexey, Zakšauskas, Audrius, Zubrienė, Asta, Petrauskas, Vytautas, Mickevičiūtė, Aurelija, Michailovienė, Vilma, Čapkauskaitė, Edita, Manakova, Elena, Gražulis, Saulius, Baranauskienė, Lina, Chen, Wen‐Yih, Ladbury, John E., Matulis, Daumantas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2021
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8095314/
https://ncbi.nlm.nih.gov/pubmed/33945229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/open.202100042
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!